HBI Deals+Insights / M&A/IPOs
UK-based Contract Development Manufacturing Organisation (CDMO) Oxford Biomedica (OXB) may be open to a private equity takeover, provided any offer meets the company's valuation expectations and supports its long-term growth ambitions.





